This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.
2025-04-30-accounts
|
Pages |
| TrustInformation |
|
| Report of theTrustees |
2-6 |
| Independent Auditor's Report to theTrustees |
7-9 |
| Statement of Financial Activities |
10 |
| Balance Sheet |
11 |
| Notes to the Financial Statements |
12-18 |
| Year |
Income |
Research Expenditure |
| 2023 |
268,423 |
162,322 |
| 2024 |
160,498 |
159,074 |
| 2025 |
281,615 |
118,387 |
|
|
|
|
|
|
Total |
Total |
|
|
Unrestricted |
|
Restricted |
|
Funds |
Funds |
|
Notes |
|
Funds |
Funds |
|
2025 |
2024 |
| Incomefrom: |
|
|
|
|
|
|
|
| Donations and legacies: |
|
|
|
|
|
|
|
| Donations |
|
|
155,613 |
116,000 |
|
271,613 |
147,189 |
| Charitable activities: |
|
|
|
|
|
|
|
| Fund raising events |
|
|
2,615 |
|
|
2,615 |
8,062 |
| Other trading activities: |
|
|
|
|
|
|
|
| Sale ofprints, cards and sweatshirts |
|
|
584 |
|
|
584 |
756 |
| Investments |
|
|
6,803 |
|
|
6,803 |
4,491 |
| Totalincome |
|
|
165,615 |
116,000 |
|
281,615 |
160,498 |
| Expenditure on: |
|
|
|
|
|
|
|
| Charitable activities |
2 |
|
95,612 |
74,502 |
|
170,114 |
225,974 |
| Raisingfunds |
3 |
|
32,586 |
|
|
32,586 |
38,162 |
| Total expenditure |
|
|
128,198 |
74,502 |
|
202,700 |
264,136 |
| Net income/(expenditure) before gains |
|
|
|
|
|
|
|
| and losses on investments |
|
|
37,417 |
41 ,498 |
|
78,915 |
(103,638) |
| Realised gains/(losses) on investments |
|
|
3,428 |
|
|
3,428 |
5,903 |
| Unrealised profits/(losses) on investments |
|
|
2,903 |
|
|
2,903 |
(583) |
| Net income/expenditure for the year |
|
|
43,748 |
41,498 |
|
85,246 |
(98,318) |
| Transfers between funds |
|
|
|
|
|
|
|
| Netmovement in funds |
|
|
43,748 |
41 ,498 |
|
85,246 |
(98,3 18) |
| Balances brought forward at I May 2024 |
|
|
258,930 |
95,487 |
|
354,417 |
E 452,735 |
| Balances carried forward at 30 April 2025 |
11 & 12 |
E |
302,678 |
E 136,985 |
E |
439,663 |
E 354,417 |
|
|
Notes |
|
2025 |
|
2024 |
| Fixed Assets |
|
|
|
|
|
|
| TangibleAssets |
|
6 |
|
90 |
|
330 |
| Investments |
|
7 |
|
375,015 |
|
272,710 |
|
|
|
|
375,105 |
|
273,040 |
| Current Assets |
|
|
|
|
|
|
| Stock |
|
8 |
|
2,191 |
|
2,510 |
| Debtors |
|
9 |
|
2,934 |
|
2,514 |
| Cash at bank and in hand |
|
|
|
67,757 |
|
139,191 |
|
|
|
|
72,882 |
|
144,215 |
| Creditors: amounts falling due within one year |
|
10 |
|
8,324 |
|
62,838 |
| Net current |
assets |
|
|
64,558 |
|
81,377 |
| Net Assets |
|
|
E |
439,663 |
E |
354,417 |
| Unrestricted |
Funds |
|
|
|
|
|
|
General fund |
11 |
|
213,574 |
|
153,231 |
|
Designated funds |
11 |
|
89,104 |
|
105,699 |
|
|
|
|
302,678 |
|
258,930 |
| RestrictedFunds |
|
12 |
|
136,985 |
|
95,487 |
|
|
|
E |
439,663 |
E |
354,417 |
Unrestricted fundsare expendable at the discretion of t |
he trustees in furtherance o |
fthe objects |
ofthecharity |
. |
|
Unrestricted |
Restricted |
Total |
Total |
| 2) Direct Charitable Expenditure |
Funds |
Funds |
2025 |
2024 |
| Grants formedical research to institutions |
64,660 |
53,727 |
118,387 |
159,074 |
| Costs ofresearch programme |
25,002 |
20,775 |
45,777 |
59,085 |
| Governance costs (Note4) |
5,950 |
|
5,950 |
7,815 |
|
€95,612 |
E74,502 |
El 70,114 |
E225,974 |
|
2025 |
2024 |
| University of Newcastle |
34,843 |
|
| University ofGlasgow |
10,619 |
43,770 |
| Salisbury NHS FoundationTrust |
12,000 |
32,083 |
| University College London |
18,545 |
44,181 |
| University ofBirmingham |
21,481 |
11,000 |
| University of Bath |
20,899 |
28,040 |
|
118,387 |
159,074 |
|
Unrestricted |
Unrestricted |
Restricted |
|
Total |
|
Total |
| 3) Cost ofGenerating Funds |
|
Funds |
Funds |
|
2025 |
|
2024 |
| Promotion and fundraising |
|
13,303 |
|
|
13,303 |
|
12,583 |
| Cost of prints, cards and sweatshirts |
|
584 |
|
|
584 |
|
1,579 |
| Overheads and governance costs (Note 4) |
|
18,699 |
|
|
18,699 |
|
24,000 |
|
E |
32,586 |
|
E |
32,586 |
E |
38,162 |
| El ,400) and for ot |
her services ofEl ,500 (2024: El ,520). |
|
|
|
|
2025 |
2024 |
| Direct charitable expenditure |
|
45,777 |
59,085 |
| Cost ofgeneratingfunds |
|
17,606 |
22,725 |
| Governance costs |
- medical research |
5,950 |
7,815 |
| Governance costs |
- fundraising |
1,092 |
1,275 |
|
|
70,426 |
90,900 |
| The Foundation employedan average of2 people during the |
year (2024: 3) |
|
|
| Staffcosts |
2025 |
|
2024 |
| Salaries and wages |
54,344 |
|
72,347 |
| Social security costs |
133 |
|
1,908 |
| Pension costs |
1,820 |
|
458 |
|
56,297 |
E |
74,713 |
| Thetotalremuneration paid to key management personnel in th |
e yearwas E60,606 (2024
- E65, |
994) |
|
| 6) Tangible Fixed Assets |
|
Office |
|
|
|
Equipment |
Total |
| Cost |
|
|
|
| At I May 2024 |
|
3,675 |
3,675 |
| Additions |
|
|
|
| Disposals |
|
(1,330) |
(1,330) |
| At 30April 2025 |
|
2,345 |
2,345 |
| Depreciation |
|
|
|
| At 1 May 2024 |
|
3,345 |
3,345 |
| Charge for theyear |
|
240 |
240 |
| On Disposals |
|
(1,330) |
(1,330) |
| At 30April 2025 |
|
2,255 |
2,255 |
| Net Book Value |
|
|
|
| At 30April 2025 |
|
90 |
90 |
| At 30 April 2024 |
|
330 |
330 |
| 7) Investments |
|
|
|
|
|
2025 |
2024 |
| Market value as at 30April 2024 |
|
272,710 |
449,381 |
| Additions |
|
207,824 |
169,273 |
| Disposals |
|
(113,544) |
(328,693) |
| Revaluation |
|
2,903 |
(2,675) |
| Increase/(decrease) in cash |
|
5,122 |
(14,576) |
| Market value as at 30April 2025 |
E |
375,015 |
E 272,710 |
| Historic cost |
E |
372,688 |
E 265,299 |
| Investments by market value |
|
2025 |
|
2024 |
| CharitiesAid UK Equity IncomeUnits Fund B |
|
|
|
9,472 |
| Royal Bank ofScotland Deposit account |
|
|
|
3 |
| Rathbones Portfolio |
|
210,716 |
|
154,032 |
| OtherBank Deposits accounts |
|
164,299 |
|
109,202 |
|
E |
375,015 |
E |
272,709 |
| 8) Stock |
|
|
|
|
|
|
2025 |
|
2024 |
| Prints |
|
90 |
|
152 |
| Branded products |
|
2,017 |
|
2,244 |
| Cards |
|
84 |
|
114 |
|
E |
2,191 |
|
2,510 |
| 9) Debtors |
|
2025 |
|
2024 |
| Prepayments and accrued income |
|
2,934 |
|
2,514 |
|
E |
2,934 |
|
2,514 |
| IO) Creditors: amountsfallingdue within one year |
|
|
|
2025 |
2024 |
| Grants payable |
2,500 |
29,359 |
| Salaries |
1,101 |
2,092 |
| Othercreditors |
243 |
449 |
| Accruals and deferred income |
4,480 |
30,938 |
|
8,324 |
62,838 |
|
|
Balance |
|
|
|
|
Balance |
|
1 |
May 2024 |
Income |
Expenditure |
Transfers |
30 |
April 2025 |
| General fund |
|
El53,231 |
165,615 |
(121,867) |
16,595 |
|
€213,574 |
| Designated formedical research |
|
€105,699 |
|
|
(16,595) |
|
E89,104 |
|
E |
258,930 |
E 165,615 |
(E121,867) |
E |
E |
302,678 |
11.1) Unrestricted Funds
- Year ended |
30 April 2024 |
|
|
|
|
|
Balance |
|
|
|
Balance |
|
1 May 2023 |
Income |
Expenditure |
Transfers |
30April 2024 |
| General fund |
248,834 |
92,498 |
(191,561) |
3,460 |
E153,231 |
| Designatedfor medical research |
E109,159 |
|
|
(3,460) |
El05,699 |
|
E357,993 |
E92,498 |
(El 91,561) |
|
258,930 |
| donations and other inco |
me held on trust to be applie |
d for specifi |
c purposes. |
|
|
|
|
|
|
Balance |
|
|
|
|
Balance |
|
I |
May 2024 |
Income |
Expenditure |
Transfers |
30 |
April 2025 |
| Medical research |
|
€95,487 |
116,000 |
(74,502) |
|
E |
136,985 |
| 12.1) Restricted Funds |
- Year ended30 April 2024 |
|
|
|
|
|
|
|
|
Balance |
|
|
|
|
Balance |
|
I |
May 2023 |
Income |
Expenditure |
Transfers |
30 |
April 2024 |
| Medical research |
|
E94,742 |
68,000 |
(67,255) |
|
|
€95,487 |
| ril 2025 are represented by: |
|
|
|
|
|
Unrestricted |
Restricted |
|
|
|
Funds |
Funds |
|
Total |
| Tangible fixed assets |
90 |
|
|
90 |
| Fixed asset investments |
238,030 |
136,985 |
|
375,015 |
| Net current assets / (liabilities) |
64,558 |
|
|
64,558 |
| Total net assets |
E 302,678 |
E 136,985 |
E |
439,663 |
| ril 2024 are represented by: |
|
|
|
|
|
Unrestricted |
Restricted |
|
|
|
Funds |
Funds |
|
Total |
| Tangible fixed assets |
330 |
|
|
330 |
| Fixed asset investments |
177,223 |
95,487 |
|
272,710 |
| Net current assets / (liabilities) |
81,377 |
|
|
81,377 |
| Total net assets |
E 258,930 |
95,487 |
E |
354,417 |
| Year end |
30 |
April |
2026 |
|
226,484 |
| Year end |
30 |
April |
2027 |
|
87,240 |
| Year end |
30 |
April |
2028 |
|
32,443 |
| Year end |
30 |
April |
2029 |
|
10,250 |
|
|
|
|
E |
356,417 |
| 16 ) ComparativeStatement of Financial Act |
ivity
- Year e |
nde |
d30 April |
20 |
24 |
|
|
|
|
|
|
|
|
|
Total |
|
|
Unrestricted |
|
|
Restricted |
|
Funds |
|
Notes |
|
Funds |
|
Funds |
|
2024 |
| Incomefrom: |
|
|
|
|
|
|
|
| Donations and legacies: |
|
|
|
|
|
|
|
| Donations |
|
|
79,189 |
|
68,000 |
|
147,189 |
| Charitable activities: |
|
|
|
|
|
|
|
| Fund raising events |
|
|
8,062 |
|
|
|
8,062 |
| Other trading activities: |
|
|
|
|
|
|
|
| Sale ofprints, cards and sweatshirts |
|
|
756 |
|
|
|
756 |
| Investments |
|
|
4,491 |
|
|
|
|
| Total income |
|
|
92,498 |
|
68,000 |
|
160,498 |
| Expenditure on: |
|
|
|
|
|
|
|
| Charitable activities |
|
|
158,719 |
|
67,255 |
|
225,974 |
| Raisingfunds |
|
|
38,162 |
|
|
|
38,162 |
| Total expenditure |
|
|
196,881 |
|
67,255 |
|
264,136 |
| Net income/(expenditure)before gains |
|
|
|
|
|
|
|
| and losses on investments |
|
|
(104,383) |
|
745 |
|
(103,638) |
| Realised profits/(losses) on investments |
|
|
5,903 |
|
|
|
5,903 |
| Unrealised profits/(losses) on investments |
|
|
(583) |
|
|
|
(583) |
| Net income/expenditureför the year |
|
|
(99,063) |
|
745 |
|
(98,318) |
| Transfers between funds |
|
|
|
|
|
|
|
| Net movement in tUnds |
|
|
(99,063) |
|
745 |
|
(98,318) |
| Balances brought forward at I May 2023 |
|
|
357,993 |
|
94,742 |
|
452,735 |
| Balances carried tönvard at 30 April 2024 |
|
E |
258,930 |
E |
95,487 |
E |
354,417 |